Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | SQLE | Q14534 | 8/20 | 0.54 |
| ▸ | FNTA | P49354 | 2/20 | 0.46 |
| ▸ | FNTB | P49356 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16444883 | 1.00 | KMT2A (0.55) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL16444884 | 1.00 | KMT2A (0.55) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL15789609 | 1.00 | KMT2A (0.55) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL15789606 | 1.00 | KMT2A (0.55) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL15789533 | 0.95 | KDM4E (0.48) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL15789535 | 0.95 | KDM4E (0.48) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL11098200 | 0.81 | ALDH1A1 (0.56) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL11098203 | 0.81 | ALDH1A1 (0.56) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL14815131 | 0.81 | ALDH1A1 (0.56) | KMT2ASQLEFNTAFNTBKDM4E | |
| SCHEMBL6191964 | 0.81 | ALOX15 (0.56) | KMT2AFNTAFNTBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9295630-B2 | Vitamin C complexes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-03-29 | — | — | US | disclosed |
| US-20150045426-A1 | VITAMIN C COMPLEXES | Universite Paris-Saclay (FR) | 2015-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045426-A1 | VITAMIN C COMPLEXES | PROC, CYP27B1, CYP24A1 | KMT2A 3357/4885SQLE 1002/4885FNTA 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.